8Atkinson TP,Balish MF,Waites KB.Epidemiology,clinicalmanifestations,pathogenesis and laboratory detection of Mycoplasma pneumoniae infection.FEMS Microbiol Rev,2008,32:956-973.
9Arnold FW,Summersgill JT,LaJoie AS,et al.A worldwide perspective of atypical pathogens in community-acquired pneumonia.Am J Respir Crit Care Med,2007,175:1086-1093.
10Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
2Loens KT,Beck D, Ursi, et al. Development of triplex SYBRgreen real-time PCR for detecting mycoplasma pneumonia,Chlamydophila pneumonia,and Legionella app[J]. J Infect Dis,2013,63(3):173-180.
3Loens K,Goossens H,Ienve M. Acute respiratory infection dueto Mycoplasma pneumonia : current status of diagnostic methods[J]. Eur J Clin Microbiol Infect Dis,2013,29(9) : 1355-1369.
4Tanaka Narita M, Teramoto S, et al. Role of interleukin-18and T-helper 1 cytokines in the development of Mycoplasmapneumonia pneumonia in adults[J]. Chest, 2012,121 (5) : 1493-1497.
6Tomohiro O, Makoto U, Tomohiro O, et al.Clinical implications of interleukin-18 levels in pediatric patients with Mycoplasma pneumoniae pneumonia[J].Journal of Infection and Chemotherapy, 2011, 17(6): 803-806.
